Literature DB >> 9950840

Dispersion-based reentry: mechanism of initiation of ventricular tachycardia in isolated rabbit hearts.

E Robert1, A G Aya, J E de la Coussaye, P Péray, J M Juan, J Brugada, J M Davy, J J Eledjam.   

Abstract

The aim of the study was to determine whether facilitation of reentry by potassium-channel openers is related to dispersion of refractoriness and/or modification of anisotropic properties of ventricular myocardium. The dispersion of ventricular effective refractory period (VERP), longitudinal and transverse ventricular conduction velocities (thetaL and thetaT, respectively), and wavelength [lambda = VERP x theta(L or T)] were studied in Langendorff-perfused left ventricular epicardium in 20 rabbits during infusion of incremental doses of levcromakalim or nicorandil. Dispersion of refractoriness was assessed using standard deviation of VERP mean (SD-VERP), dispersion index (DI; SD-VERP/mean VERP), and maximum dispersion (Dmax = VERPmax - VERPmin). Ventricular conduction velocities and anisotropic ratio were not modified, whatever the dose used. VERP and lambda were significantly shortened at high concentrations of levcromakalim and nicorandil. At these doses, SD-VERP, DI, and Dmax were increased significantly. Analysis of ventricular tachycardia induction, performed using a high-resolution ventricular mapping system, confirmed that heterogeneity and shortening of VERP were factors inducing functional conduction block. Our data suggest that, in rabbit left ventricular epicardium, functional conduction block facilitating the occurrence of reentry could be initiated by shortening and, especially, by dispersion of refractoriness during infusion of potassium-channel openers.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9950840     DOI: 10.1152/ajpheart.1999.276.2.H413

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  15 in total

1.  Does terfenadine-induced ventricular tachycardia/fibrillation directly relate to its QT prolongation and Torsades de Pointes?

Authors:  Hua Rong Lu; An N Hermans; David J Gallacher
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

Review 2.  K(ATP) channel therapeutics at the bedside.

Authors:  A Jahangir; Andre Terzic
Journal:  J Mol Cell Cardiol       Date:  2005-07       Impact factor: 5.000

Review 3.  Drug-induced QT interval shortening: potential harbinger of proarrhythmia and regulatory perspectives.

Authors:  Rashmi R Shah
Journal:  Br J Pharmacol       Date:  2009-06-25       Impact factor: 8.739

4.  Functional differences between junctional and extrajunctional adrenergic receptor activation in mammalian ventricle.

Authors:  Olujimi A Ajijola; Marmar Vaseghi; Wei Zhou; Kentaro Yamakawa; Peyman Benharash; Joseph Hadaya; Robert L Lux; Aman Mahajan; Kalyanam Shivkumar
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-12-15       Impact factor: 4.733

5.  Role of apamin-sensitive small conductance calcium-activated potassium currents in long-term cardiac memory in rabbits.

Authors:  Dechun Yin; Mu Chen; Na Yang; Adonis Z Wu; Dongzhu Xu; Wei-Chung Tsai; Yuan Yuan; Zhipeng Tian; Yi-Hsin Chan; Changyu Shen; Zhenhui Chen; Shien-Fong Lin; James N Weiss; Peng-Sheng Chen; Thomas H Everett
Journal:  Heart Rhythm       Date:  2018-01-08       Impact factor: 6.343

6.  Functional Interactions between Distinct Sodium Channel Cytoplasmic Domains through the Action of Calmodulin.

Authors:  Franck Potet; Benjamin Chagot; Mircea Anghelescu; Prakash C Viswanathan; Svetlana Z Stepanovic; Sabina Kupershmidt; Walter J Chazin; Jeffrey R Balser
Journal:  J Biol Chem       Date:  2009-01-26       Impact factor: 5.157

7.  Assessment of the Spatial QRS-T Angle by Vectorcardiography: Current Data and Perspectives.

Authors:  Christina Voulgari; Nicholas Tentolouris
Journal:  Curr Cardiol Rev       Date:  2009-11

8.  Mechanisms that initiate ventricular tachycardia in the infarcted human heart.

Authors:  Oliver R Segal; Anthony W C Chow; Nicholas S Peters; D Wyn Davies
Journal:  Heart Rhythm       Date:  2009-09-19       Impact factor: 6.343

Review 9.  Drugs and Brugada syndrome patients: review of the literature, recommendations, and an up-to-date website (www.brugadadrugs.org).

Authors:  Pieter G Postema; Christian Wolpert; Ahmad S Amin; Vincent Probst; Martin Borggrefe; Dan M Roden; Silvia G Priori; Hanno L Tan; Masayasu Hiraoka; Josep Brugada; Arthur A M Wilde
Journal:  Heart Rhythm       Date:  2009-07-08       Impact factor: 6.343

Review 10.  Cardiac repolarisation and drug regulation: assessing cardiac safety 10 years after the CPMP guidance.

Authors:  Rashmi R Shah
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.